A comprehensive analysis of 297 glycolytic regulatory genes (GRGs) in colorectal cancer revealed that a substantial proportion (51.2%) exhibited differential expression, underscoring the probable significance of glycometabolism in the pathogenesis of colorectal cancer.
← all excerpts
The pivotal role of SFRP2 in promoting glycolysis and progression in the high-risk group based on the glycometabolism prognostic model for colorectal cancer.
1
—
—